Trial intelligence / Profile preview

Aminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients

NCT06125665Unknown

Sponsor
Tanta University
Start
Nov 2023
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of aminophylline in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Tanta University. Primary endpoint: Static lung compliance. Status: unknown.

02

Drugs

aminophylline
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT06125665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06125665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call